These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 38357177)

  • 1. Values of serum neutrophil gelatinase-associated lipocalin and cystatin C after percutaneous coronary intervention for early diagnosis of contrast-induced nephropathy.
    Luo P; Ao W; Xiang D; Wang J; Liu J
    Afr Health Sci; 2023 Sep; 23(3):593-598. PubMed ID: 38357177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Predict value of monitoring changes of urinary neutrophil gelatinase-associated lipocalin and kidney injury molecule-1 after coronary angiography and percutaneous coronary intervention on early diagnosis of contrast-induced nephropathy].
    Wang L; Pu X
    Zhonghua Xin Xue Guan Bing Za Zhi; 2014 Apr; 42(4):301-4. PubMed ID: 24924456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of a Diagnostic Test of Serum Neutrophil Gelatinase-Associated Lipocalin (NGAL) and Urine KIM-1 in Contrast-Induced Nephropathy (CIN).
    Liao B; Nian W; Xi A; Zheng M
    Med Sci Monit; 2019 Jan; 25():565-570. PubMed ID: 30659575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Could neutrophil-gelatinase-associated lipocalin and cystatin C predict the development of contrast-induced nephropathy after percutaneous coronary interventions in patients with stable angina and normal serum creatinine values?
    Bachorzewska-Gajewska H; Malyszko J; Sitniewska E; Malyszko JS; Pawlak K; Mysliwiec M; Lawnicki S; Szmitkowski M; Dobrzycki S
    Kidney Blood Press Res; 2007; 30(6):408-15. PubMed ID: 17901710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluating biomarkers for contrast-induced nephropathy following coronary interventions: an umbrella review on meta-analyses.
    Mahapatro A; Nobakht S; Mukesh S; Daryagasht AA; Korsapati AR; Jain SM; Soltani Moghadam S; Moosavi R; Javid M; Hassanipour S; Prabhu SV; Keivanlou MH; Amini-Salehi E; Nayak SS
    Eur J Med Res; 2024 Apr; 29(1):210. PubMed ID: 38561791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum NGAL and FGF23 may have certain value in early diagnosis of CIN.
    Li H; Yu Z; Gan L; Peng L; Zhou Q
    Ren Fail; 2018 Nov; 40(1):547-553. PubMed ID: 30278796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of neutrophil gelatinase-associated lipocalin and cystatin C as biomarkers of acute kidney injury after ST-segment elevation myocardial infarction treated by percutaneous coronary intervention.
    Nguyen LS; Spagnoli V; Kerneis M; Hauguel-Moreau M; Barthélémy O; Collet JP; Montalescot G; Silvain J
    Arch Cardiovasc Dis; 2019 Mar; 112(3):180-186. PubMed ID: 30639197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum neutrophil gelatinase associated lipocalin (NGAL) and cystatin C as early predictors of contrast-induced acute kidney injury in patients undergoing percutaneous coronary intervention.
    Padhy M; Kaushik S; Girish MP; Mohapatra S; Shah S; Koner BC
    Clin Chim Acta; 2014 Aug; 435():48-52. PubMed ID: 24804935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum levels of neutrophil Gelatinase associated Lipocalin (NGAL) predicts hemodialysis after coronary angiography in high risk patients with acute coronary syndrome.
    Reyes LF; Severiche-Bueno DF; Bustamante CA; Murillo S; Soni NJ; Poveda M; Gomez E; Buitrago R; Rodriguez A
    BMC Nephrol; 2020 Apr; 21(1):143. PubMed ID: 32321453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The value of urinary neutrophil gelatinase-associated lipocalin for early diagnosis of contrast-induced nephropathy].
    You W; Qi CL; Ye F; Huang SL; Xie DJ; Wu ZM; Huang K; Chen KL; Huang TY; Chen SL
    Zhonghua Xin Xue Guan Bing Za Zhi; 2016 Dec; 44(12):1024-1029. PubMed ID: 28056233
    [No Abstract]   [Full Text] [Related]  

  • 11. Neutrophil Gelatinase-Associated Lipocalin as an Early Marker of Contrast-Induced Nephropathy After Elective Invasive Cardiac Procedures.
    Kafkas N; Liakos C; Zoubouloglou F; Dagadaki O; Dragasis S; Makris K
    Clin Cardiol; 2016 Aug; 39(8):464-70. PubMed ID: 27175937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cystatin C, but not urinary or serum NGAL, may be associated with contrast induced nephropathy after percutaneous coronary invasive procedures: A single center experience on a limited number of patients.
    Cecchi E; Avveduto G; D'Alfonso MG; Terreni A; Gelera E; Caldini A; Giglioli C
    Acta Med Acad; 2017 May; 46(1):34-43. PubMed ID: 28605926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum neutrophil gelatinase-associated lipocalin and cystatin C are early biomarkers of contrast-induced nephropathy after coronary angiography in patients with chronic kidney disease.
    Alharazy SM; Kong N; Saidin R; Gafor AH; Maskon O; Mohd M; Zakaria SZ
    Angiology; 2014 May; 65(5):436-42. PubMed ID: 23580616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutrophil gelatinase-associated lipocalin (NGAL) for the early detection of contrast-induced nephropathy after percutaneous coronary intervention.
    Liebetrau C; Gaede L; Doerr O; Blumenstein J; Rixe J; Teichert O; Willmer M; Weber M; Rolf A; Möllmann H; Hamm C; Nef H
    Scand J Clin Lab Invest; 2014 Mar; 74(2):81-8. PubMed ID: 24304491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early detection and intervention using neutrophil gelatinase-associated lipocalin (NGAL) may improve renal outcome of acute contrast media induced nephropathy: a randomized controlled trial in patients undergoing intra-arterial angiography (ANTI-CIN Study).
    Schilcher G; Ribitsch W; Otto R; Portugaller RH; Quehenberger F; Truschnig-Wilders M; Zweiker R; Stiegler P; Brodmann M; Weinhandl K; Horina JH
    BMC Nephrol; 2011 Aug; 12():39. PubMed ID: 21849080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma neutrophil-gelatinase-associated lipocalin and cystatin C could early diagnose contrast-induced acute kidney injury in patients with renal insufficiency undergoing an elective percutaneous coronary intervention.
    Liu XL; Wang ZJ; Yang Q; Yu M; Shen H; Nie B; Han HY; Gao F; Zhou YJ
    Chin Med J (Engl); 2012 Mar; 125(6):1051-6. PubMed ID: 22613530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomarkers for the early prediction of contrast-induced nephropathy after percutaneous coronary intervention in adults: A systematic review and meta-analysis.
    Lin J; Chen J; Wu D; Li X; Guo X; Shi S; Lin K
    Angiology; 2022 Mar; 73(3):207-217. PubMed ID: 34461746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NGAL (neutrophil gelatinase-associated lipocalin) and cystatin C: are they good predictors of contrast nephropathy after percutaneous coronary interventions in patients with stable angina and normal serum creatinine?
    Bachorzewska-Gajewska H; Malyszko J; Sitniewska E; Malyszko JS; Poniatowski B; Pawlak K; Dobrzycki S
    Int J Cardiol; 2008 Jul; 127(2):290-1. PubMed ID: 17566573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of probucol on preventing contrast-induced nephropathy in patients undergoing percutaneous coronary intervention].
    Suo XQ; Yang SC; Ma ZH; Sun TT; Zhang WY; Cong HL; Lin WH; Lu CZ; Tian FS; Fu NK
    Zhonghua Yi Xue Za Zhi; 2017 Nov; 97(41):3234-3238. PubMed ID: 29141361
    [No Abstract]   [Full Text] [Related]  

  • 20. Neutrophil gelatinase-associated lipocalin (NGAL): a promising biomarker of contrast-induced nephropathy after computed tomography.
    Filiopoulos V; Biblaki D; Vlassopoulos D
    Ren Fail; 2014 Jul; 36(6):979-86. PubMed ID: 24673459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.